Effective treatment of MDS requires an individualized, risk-adapted approach. Current strategies for the treatment of MDS, review of ongoing clinical trials and evolving agents for management of MDS will be discussed in this video.
This activity is intended for physicians, oncology nurses, nurse practitioners, physician assistants, and other health care professionals interested in the treatment and management of patients with Myelodysplastic Syndromes.
Upon completion of the educational activity, participants should be able to:
Rami Komrokji, MD
Clinical Director, Associate Professor
Department of Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Dr Komrokji has disclosed the following relevant financial relationships:
Advisory Role – Celgene, Novartis